{"lastClose": 4.070000171661377, "len": 1011, "date": "2023-04-10", "alpha_1": -0.8131082937373877, "beta_1": 0.8247833278773486, "drawup_1": 0.7155424508464454, "natr_1": 19.046756842517574, "sup_1": -0.18837019604645378, "res_1": 0.03357901966580253, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 42.03296987608132, "adx_1": 39.805197062431276, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.7977934333869705, "stratHoldAlpha_1": 250.35296400159038, "stratHoldDrawdown_1": -0.7328270378086312, "alpha_3mo": -0.803844030227887, "beta_3mo": 1.3098511352327085, "drawup_3mo": 0.11559141490594227, "natr_3mo": 19.046756842517574, "sup_3mo": -0.13677313725290352, "res_3mo": 0.00409496096398732, "bullPattern_3mo": ["CLOSINGMARUBOZU", "LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 55.67567978573786, "adx_3mo": 16.314432202093716, "drawdown_3mo": -0.31111111797913593, "stratHoldSharpe_3mo": -1.571734831731509, "stratHoldAlpha_3mo": 250.2835434366447, "stratHoldDrawdown_3mo": -0.28182665992855327, "Name": "NGM Biopharmaceuticals Inc.", "Country": "United States", "IPO Year": 2019.0, "Market Cap": 333969951, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "alpha%_1": 0.005899816532011026, "beta%_1": 0.367061313942069, "drawup%_1": 0.6639309946612407, "natr%_1": 0.9999999993656485, "drawdown%_1": 0.010606142681892014, "stratHoldSharpe%_1": 0.14251098779741972, "stratHoldAlpha%_1": 0.00814295668832394, "stratHoldDrawdown%_1": 0.010560533238723434, "alpha%_3mo": 0.12551440325453234, "beta%_3mo": 0.6644778107854281, "drawup%_3mo": 0.2988248593149989, "natr%_3mo": 0.9999999987863287, "drawdown%_3mo": 0.17184463965210145, "stratHoldSharpe%_3mo": 0.2169855430260117, "stratHoldAlpha%_3mo": 0.1464993074078731, "stratHoldDrawdown%_3mo": 0.17560678933188245}